연구동향 분석

REVIEW : Respiratory Review of 2014: Tuberculosis and Nontuberculous Mycobacterial Pulmonary Disease

( Cheol Kyu Park ) ( Yong Soo Kwon ) 2014년

논문상세정보
인용/피인용
' REVIEW : Respiratory Review of 2014: Tuberculosis and Nontuberculous Mycobacterial Pulmonary Disease' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • antitubercular agents
  • diagnosis
  • multidrug-resistant
  • nontuberculous mycobacteria
  • tuberculosis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
741 0

0.0%

' REVIEW : Respiratory Review of 2014: Tuberculosis and Nontuberculous Mycobacterial Pulmonary Disease' 의 참고문헌

  • Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
    Steingart KR Cochrane Database Syst Rev 1 : CD009593 ~ [2013]
  • Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study
    Bryant JM Lancet 381 : 1551 ~ 1560 - [2013]
  • Use of inhaled corticosteroids and the risk of tuberculosis
    Lee CH Thorax 68 : 1105 ~ 1113 - [2013]
  • Update on the epidemiology of pulmonary nontuberculous mycobacterial infections
    Kendall BA Semin Respir Crit Care Med 34 : 87 ~ 94 - [2013]
  • Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen
    Koh WJ Antimicrob Agents Chemother 57 : 2281 ~ 2285 - [2013]
  • Treatment Outcome of Combination Therapy Including Clarithromycin for Mycobacterium avium Complex Pulmonary Disease
    김은영 The Korean Journal of Internal Medicine 26 (1) : 54 ~ 59 [2011]
  • The seventh nationwide tuberculosis prevalence survey in Korea, 1995
    Hong YP Int J Tuberc Lung Dis 2 : 27 ~ 36 - [1998]
  • The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis
    Blomberg B Bull World Health Organ 79 : 61 ~ 68 [2001]
  • The promise and reality of fixed-dose combinations with rifampicin. A joint statement of the International Union Against Tuberculosis and Lung Disease and the Tuberculosis Programme of the World Health Organization
    Tuber Lung Dis 75 : 180 ~ 181 [1994]
  • Standardized Combination Antibiotic Treatment of Mycobacterium avium Complex Lung Disease
    심윤수 Yonsei Medical Journal 51 (6) : 888 ~ 894 [2010]
  • Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen
    Jo KW Respir Med 108 : 654 ~ 659 - [2014]
  • Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
    Falzon D Eur Respir J 42 : 156 ~ 168 - [2013]
  • Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulatio
    Milan-Segovia RC Int J Tuberc Lung Dis 14 : 1454 ~ 1460 - [2010]
  • Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea
    Park YS Int J Tuberc Lung Dis 14 : 1069 ~ 1071 - [2010]
  • Quality control in tuberculosis bacteriology. 1. Laboratory studies on isolated positive cultures and the efficiency of direct smear examination
    Aber VR Tubercle 61 : 123 ~ 133 - [1980]
  • Present position of microscopy and of culture in diagnostic mycobacteriology
    Urbanczik R Zentralbl Bakteriol Mikrobiol Hyg A 260 : 81 ~ 87 - [1985]
  • Phenotypic, immunologic, and clinical characteristics of patients with nontuberculous mycobacterial lung disease in Korea
    Lee AR BMC Infect Dis 13 : 558 ~ - [2013]
  • Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes
    Kartalija M Am J Respir Crit Care Med 187 : 197 ~ 205 - [2013]
  • Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense
    Shin SJ Clin Infect Dis 57 : 32 ~ 39 - [2013]
  • Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
    Ahuja SD PLoS Med 9 : e1001300 ~ - [2012]
  • Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease
    Adjemian J Ann Am Thorac Soc 11 : 9 ~ 16 - [2014]
  • Interventions for treating tuberculous pericarditis
    Mayosi BM Cochrane Database Syst Rev (4) : CD000526 ~ [2002]
  • Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD
    Kim JH Chest 143 : 1018 ~ 1024 - [2013]
  • Increasing Trend of Isolation of Non-Tuberculous Mycobacteria in a Tertiary University Hospital in South Korea
    유정완 Tuberculosis and Respiratory Diseases 72 (5) : 409 ~ 415 [2012]
  • Increasing Recovery of Nontuberculous Mycobacteria from Respiratory Specimens over a 10-Year Period in a Tertiary Referral Hospital in South Korea
    고원중 Tuberculosis and Respiratory Diseases 75 (5) : 199 ~ 204 [2013]
  • Increased Tuberculosis Burden Due to Demographic Transition in Korea from 2001 to 2010
    박영길 Tuberculosis and Respiratory Diseases 74 (3) : 104 ~ 110 [2013]
  • Guidelines for the programmatic management of drug-resistant tuberculosis-2011 update
  • Glucocorticoid use, other associated factors, and the risk of tuberculosis
    Jick SS Arthritis Rheum 55 : 19 ~ 26 - [2006]
  • Global tuberculosis report 2013
  • Fixeddose combinations improve medication compliance: a metaanalysis
    Bangalore S Am J Med 120 : 713 ~ 719 - [2007]
  • Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis
    Albanna AS Eur Respir J 42 : 721 ~ 732 - [2013]
  • Feasibility, accuracy, and clinical effect of point-ofcare Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
    Theron G Lancet 383 : 424 ~ 435 - [2014]
  • Eisenach KD, et al. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis
    Johnson JL Int J Tuberc Lung Dis 10 : 605 ~ 612 - [2006]
  • Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice
    Kwak N PLoS One 8 : e77456 ~ - [2013]
  • Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999
    Am J Respir Crit Care Med 161 (4 Pt 1) : 1376 ~ 1395 [2000]
  • Corticosteroids for prevention of mortality in people with tuberculosis: a system atic review and meta-analysis
    Critchley JA Lancet Infect Dis 13 : 223 ~ 237 - [2013]
  • Corticosteroids for managing tuberculous meningitis
    Prasad K Cochrane Database Syst Rev : CD002244 ~ - [2008]
  • Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis
    Ahmad Z Am J Respir Crit Care Med 188 : 97 ~ 102 - [2013]
  • Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model
    Cremades R J Antimicrob Chemother 66 : 2281 ~ 2283 - [2011]
  • Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis
    Koh WJ Am J Respir Crit Care Med 188 : 858 ~ 864 - [2013]
  • Clinical diagnosis of smearnegative pulmonary tuberculosis in low-income countries:the current evidence
    Siddiqi K Lancet Infect Dis 3 : 288 ~ 296 - [2003]
  • Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease
    Griffith DE Am J Respir Crit Care Med 174 : 928 ~ 934 - [2006]
  • Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea
    Lee SK Scand J Infect Dis 44 : 733 ~ 738 - [2012]
  • Bilateral bronchiectasis and bronchiolitis at thin-section CT:diagnostic implications in nontuberculous mycobacterial pulmonary infection
    Koh WJ Radiology 235 : 282 ~ 288 - [2005]
  • Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system
  • An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
    Griffith DE Am J Respir Crit Care Med 175 : 367 ~ 416 - [2007]
  • A nested case-control study on treatment-related risk factors for early relapse of tuberculosis
    Chang KC Am J Respir Crit Care Med 170 : 1124 ~ 1130 - [2004]
  • A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis
    Rustomjee R Int J Tuberc Lung Dis 12 : 128 ~ 138 [2008]